176 related articles for article (PubMed ID: 10089027)
21. An unusual case of Bence Jones myeloma with extremely low levels of monoclonal immunoglobulin.
Ozaki M; Yamanaka H
Oral Surg Oral Med Oral Pathol; 1986 May; 61(5):498-503. PubMed ID: 3086787
[TBL] [Abstract][Full Text] [Related]
22. [Renal disease in multiple myeloma].
Hiromura K; Nojima Y
Nihon Rinsho; 2007 Dec; 65(12):2229-34. PubMed ID: 18069265
[TBL] [Abstract][Full Text] [Related]
23. [Multiple myeloma. Biological, prognostic, and therapeutic aspects].
Corrado C; Pavlovsky S
Sangre (Barc); 1990 Aug; 35(4):289-97. PubMed ID: 1703328
[No Abstract] [Full Text] [Related]
24. Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
Bianchi G; Richardson PG; Anderson KC
J Clin Oncol; 2014 Jul; 32(20):2125-32. PubMed ID: 24888801
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and management of multiple myeloma and related disorders.
Kyle RA
Prog Hematol; 1986; 14():257-82. PubMed ID: 2418463
[No Abstract] [Full Text] [Related]
26. Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment.
Takemori N; Kondo K; Kawamura T; Imai K; Sakurai H; Sato T
Am J Hematol; 2001 Jan; 66(1):62-3. PubMed ID: 11426497
[TBL] [Abstract][Full Text] [Related]
27. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
28. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
29. Non-excretory IgM-kappa myeloma: report of a case.
Wang CR; Tien HF; Hsieh HC; Wang CH; Chuang CY
Taiwan Yi Xue Hui Za Zhi; 1988 Nov; 87(11):1108-11. PubMed ID: 3148682
[No Abstract] [Full Text] [Related]
30. Disappearance of nodular mesangial lesions in a patient with light chain nephropathy after long-term chemotherapy.
Komatsuda A; Wakui H; Ohtani H; Kodama T; Miki K; Imai H; Miura AB
Am J Kidney Dis; 2000 Mar; 35(3):E9. PubMed ID: 10692294
[TBL] [Abstract][Full Text] [Related]
31. Non-secretory multiple myeloma presenting as primary plasma cell leukaemia.
Sureda A; Pais JR; Pascual J; Pérez Vaquero MA; Hernando JC
Postgrad Med J; 1992 Jun; 68(800):470-2. PubMed ID: 1437933
[TBL] [Abstract][Full Text] [Related]
32. [IgM-lambda multiple myeloma presenting with systemic amyloidosis].
Higeta D; Yokohama A; Osaki Y; Tahara K; Mawatari M; Sekigami T; Koiso H; Saito T; Uchiumi H; Handa H; Karasawa M; Murakami H; Hirato J; Tsukamoto N; Nojima Y
Rinsho Ketsueki; 2009 Dec; 50(12):1711-4. PubMed ID: 20068279
[TBL] [Abstract][Full Text] [Related]
33. [A myeloma (IgG-kappa) terminating in acute myelogenous leukemia].
Fujii H; Yashige H; Taniwaki M; Urata Y; Kuzuyama Y; Kitagawa Y; Horishi M; Suyama Y; Miyoshi M
Gan No Rinsho; 1990 Apr; 36(5):645-50. PubMed ID: 2109137
[TBL] [Abstract][Full Text] [Related]
34. Root resorption caused by jaw infiltration of multiple myeloma: report of a case and literature review.
Troeltzsch M; Oduncu F; Mayr D; Ehrenfeld M; Pautke C; Otto S
J Endod; 2014 Aug; 40(8):1260-4. PubMed ID: 25069945
[TBL] [Abstract][Full Text] [Related]
35. Multiple myeloma with serum IgM kappa and Bence Jones lambda biclonal gammopathy.
Graziani MS; Lippi U
Clin Chem; 1986 Dec; 32(12):2220-1. PubMed ID: 3096615
[TBL] [Abstract][Full Text] [Related]
36. Is there any significance for intracellular crystals in plasma cells from patients with monoclonal gammopathies?
Gardais J; Geneviève F; Foussard C; Delisle V; Zandecki M
Eur J Haematol; 2001 Aug; 67(2):119-22. PubMed ID: 11722600
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous occurrence of clinical manifestations of myeloma and Waldenström's macroglobulinemia with monoclonal IgG Lambda and IgM Kappa in a single patient.
Fine JM; Gorin NC; Gendre JP; Petitpierre JC; Labro-Bryskier MT; Lambin P
Acta Med Scand; 1981; 209(3):229-34. PubMed ID: 6784449
[TBL] [Abstract][Full Text] [Related]
38. Monitoring myeloma: light chain isotype suppression. A new parameter.
Wearne A; Joshua DE; Kronenberg H
Aust N Z J Med; 1985 Oct; 15(5):629-33. PubMed ID: 3937514
[TBL] [Abstract][Full Text] [Related]
39. [Light-chain escape from plateau phase].
Jennane S; Mahtat el M; Konopacki J; Samson T; Foissaud V; Souleau B; Malfuson JV; de Revel T
Ann Biol Clin (Paris); 2013; 71(4):469-71. PubMed ID: 23906577
[TBL] [Abstract][Full Text] [Related]
40. Primary renal allograft dysfunction.
Foster K; Cohen DJ; D'Agati VD; Markowitz GS
Am J Kidney Dis; 2004 Aug; 44(2):376-81. PubMed ID: 15264198
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
